Related Experiment Videos
Alteration in brain presenilin-1 mRNA expression in sporadic Alzheimer's disease
K Isoe-Wada1, K Urakami, Y Wakutani
1Division of Neurology, Institute of Neurological Sciences, Faculty of Medicine, Tottori University, Yonago, Japan.
Abstract:
Expression of presenilin-1 (PS-1) mRNA in an alternative splicing at the 3' end of exon 3 was examined in brain tissue, lymphocytes and cultured skin fibroblasts using the RT- polymerase chain reaction (RT-PCR) method. We quantified the relative ratios of the densities of the long form of PS-1 mRNA, which contains a sequence encoding four amino acids (VRSQ, denoted as VRSQ+) to the short form, which lacks the VRSQ sequence (VRSQ-). The brain tissue of subjects with sporadic Alzheimer's disease (AD) had reduced levels of the VRSQ+ form of the PS-1 mRNA compared to a control group. No significant differences appeared in peripheral tissues, such as lymphocytes or cultured skin fibroblasts in AD with control subjects. Changes in the alternative splicing of exon 3 may be specific to the brain and may play an important role in the pathogenesis of sporadic AD.
Insights
Researchers found altered presenilin-1 (PS-1) mRNA splicing in Alzheimer's disease (AD) brain tissue. This specific splicing change, affecting the VRSQ+ form, was not observed in peripheral cells, suggesting a brain-specific role in AD pathogenesis.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Presenilin-1 (PS-1) is a key protein implicated in Alzheimer's disease (AD) pathogenesis.
- Alternative splicing of mRNA is a critical regulatory mechanism in gene expression.
- Dysregulation of PS-1 expression or function is linked to familial and sporadic forms of AD.
Purpose of the Study:
- To investigate the expression patterns of alternatively spliced PS-1 mRNA in the brain and peripheral tissues of individuals with sporadic Alzheimer's disease.
- To determine if altered splicing of PS-1 exon 3 is specific to brain tissue in AD.
- To explore the potential role of PS-1 alternative splicing in the pathogenesis of sporadic AD.
Main Methods:
- Utilized reverse transcription-polymerase chain reaction (RT-PCR) to analyze PS-1 mRNA expression.
- Quantified the relative ratios of two PS-1 mRNA isoforms: VRSQ+ (long form) and VRSQ- (short form).
- Examined tissue samples from brain, lymphocytes, and cultured skin fibroblasts.
Main Results:
- Sporadic Alzheimer's disease (AD) brain tissue exhibited significantly reduced levels of the long form (VRSQ+) of PS-1 mRNA compared to control subjects.
- No significant differences in the ratios of VRSQ+ to VRSQ- PS-1 mRNA were found in peripheral tissues (lymphocytes, fibroblasts) between AD patients and controls.
- These findings indicate a potential tissue-specific alteration in PS-1 mRNA splicing in the context of sporadic AD.
Conclusions:
- Alternative splicing of PS-1 exon 3, specifically the reduction of the VRSQ+ form, may be a brain-specific event in sporadic Alzheimer's disease.
- These splicing alterations could contribute to the neuropathological processes underlying sporadic AD.
- Further research is warranted to elucidate the functional consequences of altered PS-1 splicing in AD pathogenesis.